Showing 31-40 of 153 results for "".
- Novel TYK2 Inhibitor Shows Promising Results in Phase 2 Trials for PsOhttps://practicaldermatology.com/news/Novel-TYK2-Inhibitor-Shows-Promising-Results-Phase-2-Trials-PsO/2471545/The TYK2 inhibitor ESK-001 has shown promising safety and efficacy in long-term Phase 2 trials for moderate-to-severe plaque psoriasis, Andrew Blauvelt, MD, FAAD, said in a late-breaking research presentation at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.
- NPF Welcomes Four New Board Membershttps://practicaldermatology.com/news/npf-welcomes-four-new-board-members/2461907/The National Psoriasis Foundation (NPF) is adding four new members to the NPF Board of Directors. Andrew Blauvelt, MD, MBA, Valerie Harrison, PhD, Brian Janssen, and Diana Sandler, MD. will serve two-year terms effective July 1, 2023. Dr. Blauvelt will also serve as the Chair
- Engineered Human Tissue May Help Study Mosquito Bites, Diseaseshttps://practicaldermatology.com/news/engineered-human-tissue-may-help-study-mosquito-bites-diseases/2461774/Researchers have created engineered human tissue to study mosquito bites and the diseases they transmit. The team led by College of Medicine biomedical researcher Bradley Jay Willenberg with Mollie Jewett (UCF Burnett School of Biomedical Sciences) and Andrew Dickerson (University of Te
- Xeomin Injunction Stands; Another Hearing Scheduled for Tomorrowhttps://practicaldermatology.com/news/20120312-xeomin_injunction_stands_another_hearing_scheduled_for_tomorrow/2459848/Handing down his order as promised on Friday, US District Court Judge Andrew J. Guilford imposed a 10-month injunction barring Merz from selling or soliciting purchases of Xeomin®, in the US facial aesthetics market for 10 months. However, Judge Gui
Skin of Color Session: Dr. Taylor
https://practicaldermatology.com/programs/practical-dermatology/skin-of-color-session-dr-taylor/32674/Susan Taylor, MD, summarizes her presentation during the "Skin of Color Session" at Maui Derm 2025, including a discussion of photoprotection for patients with vitiligo, hyperpigmentation, and melasma.Taylor Made: Procedure Helps Fade Stubborn Facial Acne Scars
https://practicaldermatology.com/topics/acne-rosacea/taylor-made-procedure-helps-fade-stubborn-facial-acne-scars/23519/CSF faculty member Mark Taylor, MD describes how he treats facial acne scars.Taylor Made: One-of-a-kind Solutions for Device-based Services
https://practicaldermatology.com/topics/practice-management/taylor-made-one-of-a-kind-solutions-for-device-based-services/18789/An expert on the leading edge of device-based interventions, Mark B. Taylor, MD has learned when and how to adopt technologies and how to get the most from the systems in his practice. In this edition of Best Practices in Aesthetics, host Joel L. Cohen, MD asks Dr. Taylor to share his tips for optimSDPA: Andrew Mastro on Advancing Career By Building Yearly Goals
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-andrew-mastro-on-advancing-career-by-building-yearly-goals/29512/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Andrew Mastro, PA-C. Each year, Mastro leaves SDPA with a yearly goal in mind. He breaks down how SDPA contributes to the goal and what he does to achieve it.Andrew F. Alexis, MD, MPH
https://practicaldermatology.com/topics/general-topics/andrew-f-alexis-md-mph/21369/Physician Spotlight: Andrew C. Krakowski, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-andrew-c-krakowski-md/20842/